LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on ...

In addition to the proxy statement, STAAR has reached out to all stockholders to ask for their vote to adopt the merger ...

(Nasdaq:STAA) announced today that it filed a definitive proxy statement related to its planned merger with Alcon.

Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with ...

In conjunction with the definitive proxy filing, Staar (STAA) is mailing the following letter to Staar stockholders: “On August 5, 2025, we ...

On August 4, 2025, STAAR Surgical Company entered into a merger agreement with Alcon Research, LLC, and Rascasse Merger Sub, Inc., a subsidiary of Alcon. According to the agreemen ...

Alcon (NYSE: ALC) shares registered just barely in the plus column Tuesday. The company, purporting to be the global leader in eye care dedicated to helping people see brilliantly, announced results ...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When ...

Broadwood Partners said today that it intends to vote against the proposed acquisition of Staar Surgical (Nasdaq:STAA) by Alcon (NYSE:ALC).

The studies compared the Unity Vitreoretinal Cataract System (VCS) to the Constellation Vision System and the ...

Part of Alcon's motivations for continuing to pursue the lawsuit relates to an upcoming TV series based on the movie. The company expressed that it wants to distance itself from Tesla and Elon Musk.